IMUNEKS
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

IMUNEKS Trademark

Serial Number: 97737634 • Registration: 7877477

IMUNEKS is a trademark filed by IMUNEKS FARMA ILAÇ SANAYI VE TICARET ANONIM SIRKETI on December 30, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

IMUNEKS FARMA ILAÇ SANAYI VE TICARET ANONIM SIRKETI

PROF. DR. BÜLENT TARCAN CADDESI.
BESIKTAS ISTANBUL 34349 , TR

Entity Type: 99

Trademark Details

Filing Date

December 30, 2022

Registration Date

August 5, 2025

Published for Opposition

June 17, 2025

Goods & Services

Dietary supplements for human beings and animals, food and nutritional supplements; medical preparations for slimming purposes; food for babies; medicinal herbs and nutritionally fortified herbal beverages for medical purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 5, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 5, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 17, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 17, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 11, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 13, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 27, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 27, 2024 CRFA
ASSIGNED TO LIE
Sep 27, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 31, 2024 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 21, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
May 21, 2024 GNSL
SUSPENSION LETTER WRITTEN
May 21, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 10, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 9, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 9, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 17, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 17, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 17, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 26, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 4, 2023 NWOS
NEW APPLICATION ENTERED
Jan 3, 2023 NWAP